Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Since its discovery in 2012, the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) system has supposed a promising panorama for developing novel and highly precise genome editing-based gene therapy (GT) alternatives, leading to overcoming the challenges associated with classical GT. Classical GT aims to deliver transgenes to the cells via their random integration in the genome or episomal persistence into the nucleus through lentivirus (LV) or adeno-associated virus (AAV), respectively. Although high transgene expression efficiency is achieved by using either LV or AAV, their nature can result in severe side effects in humans. For instance, an LV (NCT03852498)- and AAV9 (NCT05514249)-based GT clinical trials for treating X-linked adrenoleukodystrophy and Duchenne Muscular Dystrophy showed the development of myelodysplastic syndrome and patient’s death, respectively. In contrast with classical GT, the CRISPR/Cas9-based genome editing requires the homologous direct repair (HDR) machinery of the cells for inserting the transgene in specific regions of the genome. This sophisticated and well-regulated process is limited in the cell cycle of mammalian cells, and in turn, the nonhomologous end-joining (NHEJ) predominates. Consequently, seeking approaches to increase HDR efficiency over NHEJ is crucial. This manuscript comprehensively reviews the current alternatives for improving the HDR for CRISPR/Cas9-based GTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Major steps in non-homologous end joining (NHEJ) and Homology-directed repair (HDR). NHEJ is initiated by binding of Ku to the DSB ends. This is followed by recruiting DNA-PKcs and other necessary scaffolding factors that bring DSB ends together. Nucleases process the incompatible ends, polymerases fill gaps, and finally, the ends are ligated by DNA ligases. This process ultimately leads to the formation of INDELs. HDR is initiated by the binding of MRN that stabilizes DSB ends. Then, 5′ exonucleases produce short-range resections followed by long-range resections. The long 3′ overhangs are directed for homology search and strand invasion by RAD51, leading to D-loops’ formation. Finally, the exchanged DNA strands are resolved, leading to precise editing. Several platforms can be used as donor templates, including long single-stranded oligodeoxynucleotide (lssDNA), single-stranded oligodeoxynucleotide (ssODN), double-stranded oligodeoxynucleotide (dsODN), and double-stranded DNA (dsDNA) which can be carried through non-viral vectors, as well as DNA templates loaded into viral vectors. For more details related to donor templates and their impact on HDR, we strongly encourage readers to review the paper by Shakirova et al., 2023 [52]. Although differences in the recognition of ssDNA (i.e., BRCA1) and dsDNA (i.e., BRCA2) have been well-documented, in both scenarios, the homologous recombination takes place, leading to precise genome editing in the context of the CRISPR/Cas9 system. This figure was created with BioRender.com.](https://figures.cochat.ai/paper-figures/837092945ecf420e921b22471c115cf2/current-strategies-for-increasing-knock-in-efficiency-in-crispr-cas9-based-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, CRISPR-Cas9-mediated HDR frequently results in monoallelic knock-ins, where only one allele is precisely modified while the other remains unedited or acquires variable indels [5].”
From Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 1×
“Online predictors score sgRNA according to their on-target activity based on sophisticated studies published by Doench et al. (2016) [93].”
BackgroundDouble nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299 · cited 1×
“PAM-out configuration, together with off-sets between 40–70 bp and 50–70 bp when nCas9 (D10A) or nCas9 (H840A) are used, respectively, have demonstrated higher on-target cleavage efficiency [39], while decreasing between 50–1500-fold the Cas9 off-target events in comparison to wtCas9 [39,94].”
BackgroundThe molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S. A., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D., Haft, D. H., Horvath, P., et al. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0299-x · Cited by 2,445
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · cited 1×
“Even though some efforts have been made to increase the Cas9 specificity without size changes resulting in several Cas9 variants (see Table 1), they have a marginal effect on the knock-in efficiency increase [26,27,33].”
BackgroundCRISPR–Cas9 Structures and Mechanisms
Jiang, F., & Doudna, J. A. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062215-010822 · Cited by 2,029 · cited 6×
“The CRISPR/Cas9 comprises a sgRNA in combination with the Cas9 endonuclease, which interacts with the targeted DNA to mediate DSB [7].”
BackgroundInfluentialCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962 · cited 1×
“By knocking out the BCL11A gene (80%), the authors found a significant increase in fetal hemoglobin synthesis [46].”
BackgroundNon-homologous DNA end joining and alternative pathways to double-strand break repair
Chang, H. H. Y., Pannunzio, N. R., Adachi, N., & Lieber, M. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.48 · Cited by 1,757
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., Zeina, C. M., Gao, X., Rees, H. A., Lin, Z., et al. (2018) · Nature · doi:10.1038/nature26155 · Cited by 1,552
DNA Damage Sensing by the ATM and ATR Kinases
Marechal, A., & Zou, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012716 · Cited by 1,514
DNA double-strand break repair-pathway choice in somatic mammalian cells
Scully, R., Panday, A., Elango, R., & Willis, N. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0152-0 · Cited by 1,457
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.162339.113 · Cited by 1,356
Chu, V. T., Weber, T., Wefers, B., Wurst, W., Sander, S., Rajewsky, K., & Kühn, R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3198 · Cited by 1,210
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Lin, S., Staahl, B. T., Alla, R. K., & Doudna, J. A. (2014) · eLife · doi:10.7554/elife.04766 · Cited by 1,189
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L., & Corn, J. E. (2016) · Nature Biotechnology · doi:10.1038/nbt.3481 · Cited by 1,098
CRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,049
Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782 · cited 1×
“Even though some efforts have been made to increase the Cas9 specificity without size changes resulting in several Cas9 variants (see Table 1), they have a marginal effect on the knock-in efficiency increase [26,27,33].”
BackgroundNimonkar, A. V., Genschel, J., Kinoshita, E., Polaczek, P., Campbell, J. L., Wyman, C., Modrich, P., & Kowalczykowski, S. C. (2011) · Genes & Development · doi:10.1101/gad.2003811 · Cited by 763
The control of DNA repair by the cell cycle
Hustedt, N., & Durocher, D. (2017) · Nature Cell Biology · doi:10.1038/ncb3452 · Cited by 738 · cited 1×
“PEER REVIEW In this regard, the cells employ different mechanisms to detect and repair DSBs. 5 of 20 NHEJ is the predominant pathway used throughout the cell cycle except in mitosis, whereas HDR becomes the dominant pathway in the S/G2 phase instead [48].”
BackgroundExpanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
Gupta, R. M., & Musunuru, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72992 · Cited by 492
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie, M. A., & Wondimu, B. Z. (2021) · Biologics: Targets and Therapy · doi:10.2147/btt.s326422 · Cited by 478
An Overview of the Molecular Mechanisms of Recombinational DNA Repair
Kowalczykowski, S. C. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016410 · Cited by 471
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Kantor, A., McClements, M., & MacLaren, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176240 · Cited by 462
DNA double strand break repair via non-homologous end-joining.
Davis, A. J., & Chen, D. J. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.04.02 · Cited by 456
RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
Song, J., Yang, D., Xu, J., Zhu, T., Chen, Y. E., & Zhang, J. (2016) · Nature Communications · doi:10.1038/ncomms10548 · Cited by 422
The molecular basis and disease relevance of non-homologous DNA end joining
Zhao, B., Rothenberg, E., Ramsden, D. A., & Lieber, M. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00297-8 · Cited by 384
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
RPA and RAD51: fork reversal, fork protection, and genome stability
Bhat, K. P., & Cortez, D. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0075-z · Cited by 349
Homology-mediated end joining-based targeted integration using CRISPR/Cas9
Yao, X., Wang, X., Hu, X., Liu, Z., Liu, J., Zhou, H., Shen, X., Wei, Y., Huang, Z., Ying, W., et al. (2017) · Cell Research · doi:10.1038/cr.2017.76 · Cited by 333
DNA-PK: A dynamic enzyme in a versatile DSB repair pathway
Davis, A. J., Chen, B. P. C., & Chen, D. J. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.02.020 · Cited by 323
Methodologies for Improving HDR Efficiency
Liu, M., Rehman, S., Tang, X., Gu, K., Fan, Q., Chen, D., & Ma, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00691 · Cited by 323
53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
Daley, J. M., & Sung, P. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01639-13 · Cited by 318 · cited 2×
“These two molecules act contrary to each These two molecules act contrary to each other, where an accumulation of 53BP1 leads to NHEJ and BRCA1 to HDR [51].”
BackgroundPost-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F., & Chin, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.019 · Cited by 299
RPA Coordinates DNA End Resection and Prevents Formation of DNA Hairpins
Chen, H., Lisby, M., & Symington, L. S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.032 · Cited by 276
Canny, M. D., Moatti, N., Wan, L. C. K., Fradet-Turcotte, A., Krasner, D., Mateos-Gomez, P. A., Zimmermann, M., Orthwein, A., Juang, Y.-C., Zhang, W., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4021 · Cited by 271
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
miR-21: a non‐specific biomarker of all maladies
Jenike, A. E., & Halushka, M. K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00272-1 · Cited by 248
Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies
Marino, N. D., Pinilla-Redondo, R., Csörgő, B., & Bondy-Denomy, J. (2020) · Nature Methods · doi:10.1038/s41592-020-0771-6 · Cited by 246
Sturzenegger, A., Burdova, K., Kanagaraj, R., Levikova, M., Pinto, C., Cejka, P., & Janscak, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.578823 · Cited by 223
CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
Charpentier, M., Khedher, A. H. Y., Menoret, S., Brion, A., Lamribet, K., Dardillac, E., Boix, C., Perrouault, L., Tesson, L., Geny, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03475-7 · Cited by 214
Mechanisms and principles of homology search during recombination
Renkawitz, J., Lademann, C. A., & Jentsch, S. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3805 · Cited by 210
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
Martin, R. M., Ikeda, K., Cromer, M. K., Uchida, N., Nishimura, T., Romano, R., Tong, A. J., Lemgart, V. T., Camarena, J., Pavel-Dinu, M., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.001 · Cited by 206
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
Sishc, B., & Davis, A. (2017) · Cancers · doi:10.3390/cancers9070081 · Cited by 181
Fu, Y.-W., Dai, X.-Y., Wang, W.-T., Yang, Z.-X., Zhao, J.-J., Zhang, J.-P., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 180
Riesenberg, S., & Maricic, T. (2018) · Nature Communications · doi:10.1038/s41467-018-04609-7 · Cited by 174 · cited 1×
“Even though these molecules can enhance the HDR between 1.7-to 10-fold [99–101, 104 ], their effect seems cell-dependent”
BackgroundInfluentialCRISPR-Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing
Chiang, T.-W. W., le Sage, C., Larrieu, D., Demir, M., & Jackson, S. P. (2016) · Scientific Reports · doi:10.1038/srep24356 · Cited by 172
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
Senturk, S., Shirole, N. H., Nowak, D. G., Corbo, V., Pal, D., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kinney, J. B., & Sordella, R. (2017) · Nature Communications · doi:10.1038/ncomms14370 · Cited by 166
Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019) · Nature Communications · doi:10.1038/s41467-019-10735-7 · Cited by 164
Ma, C. J., Gibb, B., Kwon, Y., Sung, P., & Greene, E. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1125 · Cited by 162
Structural basis of homologous recombination
Sun, Y., McCorvie, T. J., Yates, L. A., & Zhang, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03365-1 · Cited by 162
Tild-CRISPR Allows for Efficient and Precise Gene Knockin in Mouse and Human Cells
Yao, X., Zhang, M., Wang, X., Ying, W., Hu, X., Dai, P., Meng, F., Shi, L., Sun, Y. W., Yao, N., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.04.021 · Cited by 158
Nakamura, A. J., Rao, V. A., Pommier, Y., & Bonner, W. M. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10475 · Cited by 154
Kouranova, E., Forbes, K., Zhao, G., Warren, J., Bartels, A., Wu, Y., & Cui, X. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.009 · Cited by 152
A chemical compound that stimulates the human homologous recombination protein RAD51
Jayathilaka, K., Sheridan, S. D., Bold, T. D., Bochenska, K., Logan, H. L., Weichselbaum, R. R., Bishop, D. K., & Connell, P. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808046105 · Cited by 150
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
Chan, J. K., Blansit, K., Kiet, T. K., Sherman, A. E., Wong, G., Earle, C., & Bourguignon, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.01.034 · Cited by 146
Kim, H. K., Lee, S., Kim, Y., Park, J., Min, S., Choi, J. W., Huang, T. P., Yoon, S., Liu, D. R., & Kim, H. H. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0505-1 · Cited by 145
The world’s first CRISPR therapy is approved: who will receive it?
Sheridan, C. (2023) · Nature Biotechnology · doi:10.1038/d41587-023-00016-6 · Cited by 139
Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
Li, K., Wang, G., Andersen, T., Zhou, P., & Pu, W. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105779 · Cited by 123
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Gomez-Ospina, N., Scharenberg, S. G., Mostrel, N., Bak, R. O., Mantri, S., Quadros, R. M., Gurumurthy, C. B., Lee, C., Bao, G., Suarez, C. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11962-8 · Cited by 123
Self-citationOptimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
Schubert, M. S., Thommandru, B., Woodley, J., Turk, R., Yan, S., Kurgan, G., McNeill, M. S., & Rettig, G. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-98965-y · Cited by 123
Simultaneous precise editing of multiple genes in human cells
Riesenberg, S., Chintalapati, M., Macak, D., Kanis, P., Maricic, T., & Pääbo, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz669 · Cited by 122
Chang, H. H. Y., Watanabe, G., Gerodimos, C. A., Ochi, T., Blundell, T. L., Jackson, S. P., & Lieber, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752329 · Cited by 118
Paulsen, B. S., Mandal, P. K., Frock, R. L., Boyraz, B., Yadav, R., Upadhyayula, S., Gutierrez-Martinez, P., Ebina, W., Fasth, A., Kirchhausen, T., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0145-2 · Cited by 116
PAXX Is an Accessory c-NHEJ Factor that Associates with Ku70 and Has Overlapping Functions with XLF
Tadi, S. K., Tellier-Lebègue, C., Nemoz, C., Drevet, P., Audebert, S., Roy, S., Meek, K., Charbonnier, J.-B., & Modesti, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.026 · Cited by 115
XLF and APLF bind Ku80 at two remote sites to ensure DNA repair by non-homologous end joining
Nemoz, C., Ropars, V., Frit, P., Gontier, A., Drevet, P., Yu, J., Guerois, R., Pitois, A., Comte, A., Delteil, C., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0133-6 · Cited by 112
Selvaraj, S., Feist, W. N., Viel, S., Vaidyanathan, S., Dudek, A. M., Gastou, M., Rockwood, S. J., Ekman, F. K., Oseghale, A., Xu, L., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01888-4 · Cited by 110
Tools for experimental and computational analyses of off-target editing by programmable nucleases
Bao, X. R., Pan, Y., Lee, C. M., Davis, T. H., & Bao, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00431-y · Cited by 106 · cited 1×
“Several predictors are available for the in-silico evaluation of potential candidates in several genome species and different Cas proteins [91,92].”
BackgroundThe tracrRNA in CRISPR Biology and Technologies
Liao, C., & Beisel, C. L. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-022559 · Cited by 105
CRISPR-based therapeutics: current challenges and future applications
Modell, A. E., Lim, D., Nguyen, T. M., Sreekanth, V., & Choudhary, A. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.10.012 · Cited by 104
Cryo-EM of NHEJ supercomplexes provides insights into DNA repair
Chaplin, A. K., Hardwick, S. W., Stavridi, A. K., Buehl, C. J., Goff, N. J., Ropars, V., Liang, S., De Oliveira, T. M., Chirgadze, D. Y., Meek, K., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.005 · Cited by 100
Nonhomologous end joining: new accessory factors fine tune the machinery
Ghosh, D., & Raghavan, S. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.03.001 · Cited by 91
CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
Bharathkumar, N., Abraham, S., Meera, P., Aksah, S., Muthu, K., Saravanan, K. M., & Anand, T. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00422-8 · Cited by 90
Shao, S., Ren, C., Liu, Z., Bai, Y., Chen, Z., Wei, Z., Wang, X., Zhang, Z., & Xu, K. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.09.012 · Cited by 89
Non-homologous end joining in class switch recombination: the beginning of the end
Kotnis, A. L., Du, L., Liu, C., Popov, S., & Pan‐Hammarström, Q. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0196 · Cited by 88
CRISPR-Cas9 technology: applications and human disease modelling
Torres-Ruiz, R., & Rodríguez, S. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw025 · Cited by 88
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Riesenberg, S., Kanis, P., Macak, D., Wollny, D., Düsterhöft, D., Kowalewski, J., Helmbrecht, N., Maricic, T., & Pääbo, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01949-1 · Cited by 87
Wang, Y., Liu, K. I., Sutrisnoh, N.-A. B., Srinivasan, H., Zhang, J., Li, J., Zhang, F., Lalith, C. R. J., Xing, H., Shanmugam, R., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1445-x · Cited by 86
Hu, Z., Shi, Z., Guo, X., Jiang, B., Wang, G., Luo, D., Chen, Y., & Zhu, Y.-S. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0200-z · Cited by 83
Schulte-Uentrop, L., El-Awady, R. A., Schliecker, L., Willers, H., & Dahm-Daphi, J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn094 · Cited by 79
Unifying the DNA End-processing Roles of the Artemis Nuclease
Chang, H. H., Watanabe, G., & Lieber, M. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680900 · Cited by 73
Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
Tran, N.-T., Bashir, S., Li, X., Rossius, J., Chu, V. T., Rajewsky, K., & Kühn, R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00365 · Cited by 72
De Ravin, S. S., Brault, J., Meis, R. J., Liu, S., Li, L., Pavel-Dinu, M., Lazzarotto, C. R., Liu, T., Koontz, S. M., Choi, U., et al. (2021) · Blood · doi:10.1182/blood.2020008503 · Cited by 72
Essential role for polymerase specialization in cellular nonhomologous end joining
Pryor, J. M., Waters, C. A., Aza, A., Asagoshi, K., Strom, C., Mieczkowski, P. A., Blanco, L., & Ramsden, D. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505805112 · Cited by 68
DNA Ligase IV Guides End-Processing Choice during Nonhomologous End Joining
Conlin, M. P., Reid, D. A., Small, G. W., Chang, H. H., Watanabe, G., Lieber, M. R., Ramsden, D. A., & Rothenberg, E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.091 · Cited by 67
Maggio, I., Zittersteijn, H. A., Wang, Q., Liu, J., Janssen, J. M., Ojeda, I. T., van der Maarel, S. M., Lankester, A. C., Hoeben, R. C., & Gonçalves, M. A. F. V. (2020) · Gene Therapy · doi:10.1038/s41434-019-0119-y · Cited by 65
Structural insights into a high fidelity variant of SpCas9
Guo, M., Ren, K., Zhu, Y., Tang, Z., Wang, Y., Zhang, B., & Huang, Z. (2019) · Cell Research · doi:10.1038/s41422-018-0131-6 · Cited by 65
Nuclease dead Cas9 is a programmable roadblock for DNA replication
Whinn, K. S., Kaur, G., Lewis, J. S., Schauer, G. D., Mueller, S. H., Jergic, S., Maynard, H., Gan, Z. Y., Naganbabu, M., Bruchez, M. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49837-z · Cited by 63
Ma, L., Ruan, J., Song, J. W., Wen, L., Yang, D., Zhao, J., Xia, X., Chen, Y. E., Zhang, J., & Xu, J. (2020) · Nature Communications · doi:10.1038/s41467-020-19842-2 · Cited by 61
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Liu, N., Zhou, L., Lin, G., Hu, Y., Jiao, Y., Wang, Y., Liu, J., Yang, S., & Yao, S. (2022) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2022.05.036 · Cited by 58
Ikeda, A., Fujii, W., Sugiura, K., & Naito, K. (2019) · Communications Biology · doi:10.1038/s42003-019-0627-8 · Cited by 57
Improving Precise CRISPR Genome Editing by Small Molecules: Is there a Magic Potion?
Bischoff, N., Wimberger, S., Maresca, M., & Brakebusch, C. (2020) · Cells · doi:10.3390/cells9051318 · Cited by 56
Potentiation of gene targeting in human cells by expression of Saccharomyces cerevisiae Rad52
Primio, C. D., Galli, A., Cervelli, T., Zoppè, M., & Rainaldi, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki778 · Cited by 54
Suppressing Ku70/Ku80 expression elevates homology-directed repair efficiency in primary fibroblasts
Li, G., Liu, D., Zhang, X., Quan, R., Zhong, C., Mo, J., Huang, Y., Wang, H., Ruan, X., Xu, Z., et al. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.011 · Cited by 51
Shams, F., Bayat, H., Mohammadian, O., Mahboudi, S., Vahidnezhad, H., Soosanabadi, M., & Rahimpour, A. (2022) · BioImpacts · doi:10.34172/bi.2022.23871 · Cited by 51
Matsumoto, D., Tamamura, H., & Nomura, W. (2020) · Communications Biology · doi:10.1038/s42003-020-01340-2 · Cited by 49
Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases
Kanafi, M. M., & Tavallaei, M. (2022) · Gene · doi:10.1016/j.gene.2022.146518 · Cited by 41
Preserving genome integrity in human cells via DNA double-strand break repair
Jensen, R. B., & Rothenberg, E. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-10-0668 · Cited by 39
Ma, Y., Han, X., Quintana Bustamante, O., Bessa de Castro, R., Zhang, K., Zhang, P., Li, Y., Liu, Z., Liu, X., Ferrari, M., et al. (2017) · Integrative Biology · doi:10.1039/c7ib00060j · Cited by 38
Recent advances in the engineering and application of streptavidin-like molecules
Le, Q., Nguyen, V., & Park, S. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10036-5 · Cited by 38
Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors
Li, G., Zhang, X., Wang, H., Liu, D., Li, Z., Wu, Z., & Yang, H. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105790 · Cited by 38
Gene therapy for sickle cell disease
Leonard, A. K., & Tisdale, J. F. (2023) · Hematology · doi:10.1182/hematology.2023000487 · Cited by 37
Crystal structure of xCas9 in complex with sgRNA and target DNA (AAG PAM): 6aeb
Guo, M., Ren, K., Zhu, Y., & Huang, Z. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6aeb/pdb · Cited by 36
Ku70 suppresses alternative end joining in G1-arrested progenitor B cells
Liang, Z., Kumar, V., Bouteiller, M. L., Zurita, J., Kenrick, J., Lin, S. G., Lou, J., Hu, J., Ye, A. Y., Boboilă, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103630118 · Cited by 35
Shakirova, A. I., Karpov, T. E., Komarova, Y., & Lepik, K. V. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1068637 · Cited by 34
CRISPR/Cas therapeutic strategies for autosomal dominant disorders
Caruso, S. M., Quinn, P. M. J., da Costa, B. L., & Tsang, S. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158287 · Cited by 29
Leal, A. F., & Alméciga-Díaz, C. J. (2022) · Gene Therapy · doi:10.1038/s41434-022-00344-3 · Cited by 29
Self-citationThe landscape of CRISPR/Cas9 for inborn errors of metabolism
Leal, A. F., Nidhi, F., Benincore-Flórez, E., Herreño-Pachón, A. M., Echeverri-Peña, O. Y., Alméciga-Díaz, C. J., & Tomatsu, S. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.106968 · Cited by 29
Self-citationFusing an exonuclease with Cas9 enhances homologous recombination in Pichia pastoris
Zhang, K., Duan, X., Cai, P., Gao, L., Wu, X., Yao, L., & Zhou, Y. J. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01908-z · Cited by 28
Park, S. B., Uchida, T., Tilson, S. G., Hu, Z., Ma, C. D., Leek, M., Eichner, M., Hong, S. G., & Liang, T. J. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.013 · Cited by 27
Choudhary, N., Tandi, D., Verma, R. K., Yadav, V. K., Dhingra, N., Ghosh, T., Choudhary, M., Gaur, R. K., Abdellattif, M. H., Gacem, A., et al. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1164461 · Cited by 27
HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs
Zhang, J., Yang, Z.-X., Zhang, F., Fu, Y.-W., Dai, X., Wen, W., Zhang, B., Choi, H., Chen, W., Brown, M., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1855-4 · Cited by 26
Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice
Leal, A. F., Çelik, B., Nidhi, F., Khan, S. A., Tomatsu, S., & Alméciga-Díaz, C. J. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101153 · Cited by 24
Self-citationDallaire, F., Schreiner, S., Blair, G. E., Dobner, T., Branton, P. E., & Blanchette, P. (2015) · mSphere · doi:10.1128/msphere.00015-15 · Cited by 19
Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges
Batool, A., Malik, F. A., & Andrabi, K. I. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00500-8 · Cited by 15
Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells
Shahryari, A., Moya, N., Siehler, J., Wang, X., Burtscher, I., & Lickert, H. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0014 · Cited by 15
Cas9‐Geminin and Cdt1‐fused anti‐CRISPR protein synergistically increase editing accuracy
Matsumoto, D., Kishi, K., Matsugi, E., Inoue, Y., Nigorikawa, K., & Nomura, W. (2023) · FEBS Letters · doi:10.1002/1873-3468.14608 · Cited by 14
Richardson, R. R., Steyert, M. R., Khim, S. N., Crutcher, G. W., Brandenburg, C., Robertson, C. D., Romanowski, A. J., Inen, J., Altas, B., & Poulopoulos, A. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0036 · Cited by 14
Lee, A. B. C., Tan, M. H., & Chai, C. L. L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.006 · Cited by 13
Finney, M., Romanowski, J. S., & Adelman, Z. N. (2022) · Virology Journal · doi:10.1186/s12985-022-01859-2 · Cited by 13
Carneiro, P., de Freitas, M. V., & Matte, Ú. D. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262299 · Cited by 11
Pigs with an INS point mutation derived from zygotes electroporated with CRISPR/Cas9 and ssODN
Tanihara, F., Hirata, M., Namula, Z., Kim, L. T., Yoshimura, N., Lin, Q., Takebayashi, K., Sakuma, T., Yamamoto, T., & Otoi, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.884340 · Cited by 9
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
Molugu, K., Khajanchi, N., Lazzarotto, C. R., Tsai, S. Q., & Saha, K. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0033 · Cited by 8
CRISPR/Cas-mediated genome editing in mice for the development of drug delivery mechanism
Ramachandregowda, S., Muktha, H., Ramakrishnaiah, T. N., Surendra, A. S., Tanvi, Y., Nivitha, K., & Rajashekara, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08659-z · Cited by 7
Rapid clonal identification of biallelic CRISPR/Cas9 knock-ins using SNEAK PEEC
Singh, S. K., Banerjee, A., Broeck, A. V., & Klinge, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-28732-8 · Cited by 6
Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7
Anuchina, A. A., Zaynitdinova, M. I., Demchenko, A. G., Evtushenko, N. A., Лавров, А. В., & Smirnikhina, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076704 · Cited by 5
Cited by
Gene therapy for genetic diseases: challenges and future directions
Beibei, Q. I. E., Tuo, J., Chen, F., Ding, H., & Lyu, L. (2025) · MedComm · doi:10.1002/mco2.70091 · Cited by 45
Gene editing and CRISPR-dependent homology-mediated end joining
Ruis, B. L., Bielinsky, A., & Hendrickson, E. A. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01442-z · Cited by 26
Retina-directed gene therapy: Achievements and remaining challenges
Biber, J., Gandor, C. L. A., Bećirović, E., & Michalakis, S. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108862 · Cited by 25
Yan, B., Yan, C., Ding, Y., Cai, S., Wang, Y., Agbo, E., Xu, X., Qin, K., & Fu, Q. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1723885 · Cited by 12
Yu, C., Adavikolanu, R., Kaake, R. M., & Huang, L. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21926 · Cited by 10
Metadata
- Authors
- Leal, A., Herreno-Pachón, A., Benincore-Flórez, E., Karunathilaka, A., & Tomatsu, S.
- Affiliations
- Pontificia Universidad Javeriana (CO)
- Nemours Children’s Health, Wilmington, DE 19803, USA
- Nemours Children's Health System (US)
- Thomas Jefferson University (US)
- Corresponding author
- Tomatsu, Shunji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-02-20
- Volume
- 25
- Issue
- 5
- Pages
- 2456
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10931195
- OpenAlex
- W4391968889
- Cited by
- 58
- References
- 130
- Citations by year
- 2026: 23 · 2025: 29 · 2024: 6
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Medicine Forum (submittedVersion, cc-by)
- Funders
- A Cure for Robert, Inc. (1R01HD102545-01A1)
- Austrian MPS society (1R01HD102545-01A1)
- The Carol Ann Foundation (1R01HD102545-01A1)
- Angelo R. Cali and Mary V. Cali Family Foundation, Inc. (1R01HD102545-01A1)
- The Vain and Harry Fish Foundation, Inc. (1R01HD102545-01A1)
- The Bennett Foundation (1R01HD102545-01A1)
- Jacob Randall Foundation (1R01HD102545-01A1)
- Nemours Funds (1R01HD102545-01A1)
- Eunice Kennedy Shriver (1R01HD102545-01A1)
- National Institute of Child Health and Human Development of the National Institutes of Health (NICHD) (1R01HD102545-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, knock-in efficiency, homologous recombination, non-homologous end joining, genome editing, gene therapy, lentivirus, adeno-associated virus, X-linked adrenoleukodystrophy, Duchenne muscular dystrophy, myelodysplastic syndrome
- MeSH terms
- Gene Editing, Animals, Humans, Mammals, Genetic Therapy, DNA End-Joining Repair, Recombinational DNA Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.